Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease

BACKGROUND: Although renin-angiotensin II-aldosterone system inhibitor (RASI) use for renal protection is well-documented, adherence to RASI therapy in the pediatric population is unclear. This study aimed to evaluate patient characteristics associated with adherence to chronic RASI use in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chien-Ning, Huang, Shiou-Huei, Tain, You-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383266/
https://www.ncbi.nlm.nih.gov/pubmed/30786856
http://dx.doi.org/10.1186/s12887-019-1434-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383266/
https://www.ncbi.nlm.nih.gov/pubmed/30786856
http://dx.doi.org/10.1186/s12887-019-1434-6

Ejemplares similares